402 related articles for article (PubMed ID: 3263507)
21. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
22. [Is the Raji cell test suitable as a marker of systemic lupus erythematosus activity? A case report].
Michel B; Schlumpf U; Fritschy J; Wagenhäuser FJ
Schweiz Med Wochenschr; 1987 Nov; 117(47):1866-74. PubMed ID: 3501164
[TBL] [Abstract][Full Text] [Related]
23. Anti C1q antibodies in cutaneous lupus erythematosus.
Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
[TBL] [Abstract][Full Text] [Related]
24. The Raji cell radioimmunoassay in patients with systemic lupus erythematosus: clinical significance and relationship to other serologic variables assessed by discriminant analysis.
Andrews BS; Ascher MS; Barada FA; Davis JS
J Rheumatol; 1985 Aug; 12(4):718-23. PubMed ID: 4057195
[TBL] [Abstract][Full Text] [Related]
25. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
26. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
Wener MH; Mannik M; Schwartz MM; Lewis EJ
Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
[TBL] [Abstract][Full Text] [Related]
27. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
28. Circulating DNA-anti-DNA complexes in lupus nephritis and idiopathic nephritis.
Williams DG; Adu D
Proc Eur Dial Transplant Assoc; 1980; 17():629-36. PubMed ID: 6787585
[TBL] [Abstract][Full Text] [Related]
29. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.
Scullion M; Balint G; Whaley K
J Clin Lab Immunol; 1979 Apr; 2(1):15-22. PubMed ID: 95801
[TBL] [Abstract][Full Text] [Related]
31. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
32. Circulating immune complexes and the complements system in lupus nephropathy.
Serban MG
Rom J Intern Med; 1992; 30(2):119-25. PubMed ID: 1496264
[TBL] [Abstract][Full Text] [Related]
33. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
[TBL] [Abstract][Full Text] [Related]
34. [Clinical relevance of circulating immune complexes in patients with systemic lupus erythematosus and chronic polyarthritis].
Menzel EJ; Smolen JS; Knapp W; Scherak O; Steffen C
Acta Med Austriaca; 1979; 6(5):212-4. PubMed ID: 162334
[TBL] [Abstract][Full Text] [Related]
35. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q.
Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G
J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
Antes U; Heinz HP; Loos M
Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
[TBL] [Abstract][Full Text] [Related]
37. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
38. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
Harkiss GD; Hazleman BL; Brown DL
J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
40. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
